Client’s Goals

Our client, a top-20 global antimicrobial susceptibility testing market leader, engaged MarketsandMarkets to secure revenue streams. Our team offered a comprehensive view of shifting revenue sources in client’s clients’ and their clients’ businesses. This helped in the identification of opportunities and blind spots in the interconnected ecosystem. Further, we defined and solved a series of problems for tapping into new growth avenues. We provided insights into global Antimicrobial Susceptibility Testing (AST) market. Few of the questions answered during the engagement were:

• Understanding of the antimicrobial susceptibility testing (AST) market by sample type
• Insights into regional market size, by value (USD million) of AST of various sample types (positive blood cultures, urine samples, respiratory tract, abdominal, sterile fluids, wounds, and other samples)
• Understanding of the major factors influencing the market (drivers, restraints, opportunities, and challenges) at the regional level

Our Approach

Our team offered detailed insights into the adjacent markets, technological disruptions, and changing revenue mixes in the interconnected ecosystem through KnowledgeStore, our AI-driven market intelligence platform. Further, authentic secondary sources such as government websites, annual reports, corporate presentations, proprietary databases were browsed to gain an understanding of the market dynamics and trends. We conducted a multi-level, qualitative, and quantitative study with a constructed sample of mid-to-senior level management executives as well as industry professionals from the supply side to understand regional level adoption, the share of subsegments in the overall market, the competitive scenario, and growth prospects. At each level, the data was verified by conducting primary interviews with industry experts (both, from demand and supply sides) across each of the target regions to capture and analyze current and forecast quantitative market information and estimates which was finally analyzed by our domain experts to derive an unbiased final output.

Our analysts expanded understanding of the major factors influencing the adoption of AST for each sample type (drivers, restraints, opportunities, and challenges). We provided insights on the current and forecast global and regional market size for antimicrobial susceptibility testing for each sample type.  Recommendations provided by our client services team helped the client to develop strategies to maximize business growth.

Revenue Shifts Identified

Pathogen identification/detection technologies are undergoing a significant shift with the advent of molecular diagnostic techniques (such as PCR & NGS) that offers early and accurate pathogen detection capabilities as compared to traditional culture-based techniques.

Interconnections

Diagnostic lab ecosystem across major markets (US & Europe) are undergoing consolidation to improve their profit margins and streamline their capacity utilization. Integration of laboratory workflow coupled with automation of sample preparation & related processes are expected to reduce the turn-around time for key end user facilities.

Unknowns Identified

Emergence of microfluidics and lab-on-chips is poised to offer renewed growth opportunities to the various service providers; as it offers affordable, portable, and point-of-care diagnostic capabilities coupled with early and accurate pathogen detection.

Revenue Impact (RI)

Our insights helped the client to identify USD 130 million worth of additional revenue opportunities in antimicrobial susceptibility testing market worldwide.